
Health and Happiness (H&H) International Holdings Limited
1112.HKHKSEConsumer DefensivePackaged Foods
最新数据
HK$14.87
−HK$0.59 · -3.82%
1112.HK公司概览
盘中时间采用HKT。市场数据可能有所延迟。
公司概况
公司网站As an investment holding entity, Health and Happiness (H&H) International Holdings Limited specializes in the global production and distribution of nutritional and care products designed for families and infants. Its offerings are categorized into several key segments. The Infant Formulas division crafts nutritional formulas for children up to age seven, alongside specialized milk products for pregnant and breastfeeding women. The Probiotic Supplements division provides various forms of probiotics, including sachets, capsules, and tablets, catering to the needs of babies, children, and expecting mothers. Within its Adult Nutrition and Care Products segment, H&H develops and markets a range of items such as vitamins, general health supplements, skincare solutions, and sports nutrition for grown-ups. Complementing its infant offerings, the Other Pediatric Products segment focuses on manufacturing dried baby foods, additional nutritional supplements, and general baby care items. Furthermore, its Pet Nutrition and Care segment creates pet food, health-enhancing supplements, and bone broth products for animals. Beyond these core product lines, the company's activities extend to research, development, and processing of diverse ingredients like meat, fruit, and vegetable powders, as well as candies. It actively researches, develops, manufactures, and sells specialized nutritional foods, manages the marketing and distribution of organic baby foods, and handles the wholesale, retail, import, and export of infant nutritional and personal care products. H&H also engages in the trading and sale of adult vitamins, health supplements, probiotic skincare, and sports nutrition items, while offering online sales platforms, software and IT solutions, and packaging services. Its extensive product portfolio is marketed under well-known brands such as Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII. Established in 1999, the company adopted its current name, Health and Happiness (H&H) International Holdings Limited, in June 2017, having previously operated as Biostime International Holdings Limited. Headquartered in Quarry Bay, Hong Kong, H&H functions as a subsidiary of Biostime Pharmaceuticals (China) Limited.
- 行业
- Packaged Foods
- 部门
- Consumer Defensive
- 总部
- HK
- 首席执行官
- Akash Bedi
- 上市以来
- 2010年12月17日
- 雇员
- 2,758
市场位置
日内区间
当前HK$14.87,
52周区间
当前HK$14.87,
- 开盘价
- HK$15.27
- 前收盘价
- HK$15.46
- 成交量
- 75.1万
- 0.32× 平均值
- 平均成交量
- 237.17万
- 日均成交量
- 市值
- 95.99亿 HKD
- 贝塔
- 1.36
- 市场参考 1
- 50天平均值
- HK$13.6994
- 高于平均水平+8.54%
- 200天平均值
- HK$13.644
- 高于平均水平+8.99%
财务数据
财务快照
最近十二个月估值与收益率
- 企业价值
- 149.32亿 CNY
- 市盈率(TTM)
- 42.51×
- 市净率(TTM)
- 1.37×
- 市销率(TTM)
- 0.57×
- EV/EBITDA
- 8.4×
- 盈利收益率
- 2.59%
- 自由现金流收益率
- 12.52%
- 股息率
- 2.35%
盈利能力和效率
- 毛利率
- 62.45%
- 营业利润率
- 11.63%
- 净利润率
- 1.37%
- 净资产收益率
- 3.27%
- 资产收益率
- 1.01%
- 投入资本回报率
- 3.66%
财务健康
- 负债权益比
- 1.51×
- 流动比率
- 1.15×
财务报表
利润率趋势
盈利能力占已公布营收的百分比。
损益趋势
营收
营业利润
净利润
| 项目(CNY) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 143.54亿 CNY | 130.52亿 CNY | 139.26亿 CNY | 127.76亿 CNY | 115.48亿 CNY |
| 销货成本 | 53.9亿 CNY | 51.36亿 CNY | 54.54亿 CNY | 50.72亿 CNY | 43亿 CNY |
| 毛利 | 89.64亿 CNY | 79.16亿 CNY | 84.73亿 CNY | 77.03亿 CNY | 72.48亿 CNY |
| 研究与开发 | 2.16亿 CNY | 2.43亿 CNY | 2.06亿 CNY | 1.58亿 CNY | 1.44亿 CNY |
| 销售、一般及管理费用 | 70.78亿 CNY | 63.49亿 CNY | 64.34亿 CNY | 59.63亿 CNY | 56.68亿 CNY |
| 营业费用 | 72.94亿 CNY | 63.43亿 CNY | 66.41亿 CNY | 59.32亿 CNY | 56.33亿 CNY |
| 利息收入 | 1721.8万 CNY | 2057.1万 CNY | 3022.7万 CNY | 2001.9万 CNY | 1188.2万 CNY |
| 利息支出 | 6.86亿 CNY | 8.7亿 CNY | 8.08亿 CNY | 5.3亿 CNY | 2.64亿 CNY |
| 折旧和摊销 | 2.17亿 CNY | 3.01亿 CNY | 3.02亿 CNY | 3.11亿 CNY | 3.05亿 CNY |
| 营业利润 | 16.7亿 CNY | 15.72亿 CNY | 18.32亿 CNY | 16.07亿 CNY | 15.12亿 CNY |
| 净利润 | 1.96亿 CNY | −5372.1万 CNY | 5.82亿 CNY | 6.12亿 CNY | 5.08亿 CNY |
公司数据更新于 2026年8月24日。
1112.HK同业公司
持有1112.HK的ETF
报告持有此股票敞口的交易所交易基金。
Vanguard Total International Stock ETFVXUS578.69万0.00%6462亿 USD0.05%US$87.2775-0.49%
Vanguard FTSE Emerging Markets ETFVWO552.77万0.00%1623亿 USD0.06%US$59.99-0.76%
iShares Core MSCI EAFE ETFIEFA336.6万0.00%1951.41亿 USD0.07%US$100.74-0.11%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS183.65万0.01%136亿 USD0.06%US$159.25-0.51%
iShares MSCI EAFE Small-Cap ETFSCZ155.48万0.01%132.82亿 USD0.40%US$86.58-0.02%
iShares Core MSCI Total International Stock ETFIXUS95.14万0.00%609.08亿 USD0.07%US$97.485-0.47%
Dimensional - Emerging Markets Core Equity 2 ETFDFEM76.8万0.01%94.91亿 USD0.39%US$39.575-0.89%
iShares Core MSCI International Developed Markets ETFIDEV65.56万0.00%326.04亿 USD0.04%US$93.151-0.17%
Vanguard Total International Stock ETFVXUS- 市场价值
- 578.69万
- 重量
- 0.00%
- AUM
- 6462亿 USD
- 费用率
- 0.05%
- 价格 / 1日
- US$87.2775-0.49%
Vanguard FTSE Emerging Markets ETFVWO- 市场价值
- 552.77万
- 重量
- 0.00%
- AUM
- 1623亿 USD
- 费用率
- 0.06%
- 价格 / 1日
- US$59.99-0.76%
iShares Core MSCI EAFE ETFIEFA- 市场价值
- 336.6万
- 重量
- 0.00%
- AUM
- 1951.41亿 USD
- 费用率
- 0.07%
- 价格 / 1日
- US$100.74-0.11%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS- 市场价值
- 183.65万
- 重量
- 0.01%
- AUM
- 136亿 USD
- 费用率
- 0.06%
- 价格 / 1日
- US$159.25-0.51%
iShares MSCI EAFE Small-Cap ETFSCZ- 市场价值
- 155.48万
- 重量
- 0.01%
- AUM
- 132.82亿 USD
- 费用率
- 0.40%
- 价格 / 1日
- US$86.58-0.02%
iShares Core MSCI Total International Stock ETFIXUS- 市场价值
- 95.14万
- 重量
- 0.00%
- AUM
- 609.08亿 USD
- 费用率
- 0.07%
- 价格 / 1日
- US$97.485-0.47%
Dimensional - Emerging Markets Core Equity 2 ETFDFEM- 市场价值
- 76.8万
- 重量
- 0.01%
- AUM
- 94.91亿 USD
- 费用率
- 0.39%
- 价格 / 1日
- US$39.575-0.89%
iShares Core MSCI International Developed Markets ETFIDEV- 市场价值
- 65.56万
- 重量
- 0.00%
- AUM
- 326.04亿 USD
- 费用率
- 0.04%
- 价格 / 1日
- US$93.151-0.17%
继续GoAI的研究
在 GoAI 中研究1112.HKresearch.disclaimer





